Cargando…
Can Treatment with Venetoclax for Chronic Lymphocytic Leukemia (CLL) Result In Autoimmune Hemolytic Anemia?
Patient: Female, 62-year-old Final Diagnosis: Autoimmune hemolytic anemia Symptoms: Anemia Medication:— Clinical Procedure: — Specialty: Hematology OBJECTIVE: Unusual clinical course BACKGROUND: Chronic lymphocytic leukemia (CLL) is a hematological disease characterized by the clonal proliferation a...
Autores principales: | Abdel-Samad, Nizar, Sughayar, Rana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7957329/ https://www.ncbi.nlm.nih.gov/pubmed/33750754 http://dx.doi.org/10.12659/AJCR.928514 |
Ejemplares similares
-
Venetoclax for treating refractory autoimmune hemolytic anemia in chronic lymphocytic leukemia: report of two cases in Spain
por: Galindo-Navarro, Pablo, et al.
Publicado: (2023) -
Autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia
por: Al Hadidi, Samer, et al.
Publicado: (2020) -
Autoimmune Hemolytic Anemia in Chronic Lymphocytic Leukemia: A Comprehensive Review
por: Autore, Francesco, et al.
Publicado: (2021) -
The Role of Novel Agents in Treating CLL-Associated Autoimmune Hemolytic Anemia
por: Noto, Alessandro, et al.
Publicado: (2021) -
Autoimmune Hemolytic Anemia in Chronic Myeloid Leukemia
por: Hamamyh, Tahseen, et al.
Publicado: (2020)